Eversept Partners, LP 13F holdings, Q4 2024
Holdings as of December 31, 2024 · filings on SEC EDGAR · latest filing →
Eversept Partners, LP disclosed 62 US equity positions worth $969.1m in its Q4 2024 13F filing. The largest position was NTRA at 14.3% of the reported book, followed by GSK and VERA. Against the Q3 2024 filing, it opened 12 new positions, added to 13 and reduced 20 among the top 50 holdings.
What did Eversept Partners, LP own in Q4 2024? Top 50 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q3 2024 |
|---|---|---|---|---|---|---|---|
| 1 | NTRA NATERA INC | Healthcare | 14.3% | $138.8m | 876,766 | 1% | added |
| 2 | GSK GSK PLC | Healthcare | 12.8% | $123.8m | 3,661,768 | -10% | reduced |
| 3 | VERA VERA THERAPEUTICS INC | Healthcare | 7.0% | $67.7m | 1,600,015 | -22% | reduced |
| 4 | INSP INSPIRE MED SYS INC | Healthcare | 5.6% | $54.6m | 294,302 | 7% | added |
| 5 | HCA HCA HEALTHCARE INC | Healthcare | 5.4% | $52.8m | 175,808 | 36% | added |
| 6 | TEVA TEVA PHARMACEUTICAL INDS LTD | Healthcare | 5.1% | $49.4m | 2,242,125 | -31% | reduced |
| 7 | RVTY REVVITY INC | Healthcare | 4.5% | $43.8m | 392,518 | -16% | reduced |
| 8 | HQY HEALTHEQUITY INC | Healthcare | 3.8% | $37.1m | 386,697 | 21% | added |
| 9 | ZIMV ZIMVIE INC | 3.0% | $28.9m | 2,070,780 | 0% | held | |
| 10 | PTGX PROTAGONIST THERAPEUTICS INC | Healthcare | 2.7% | $26.2m | 678,787 | 52% | added |
| 11 | TECH BIO-TECHNE CORP | Healthcare | 2.2% | $21.6m | 299,310 | -55% | reduced |
| 12 | CLDX CELLDEX THERAPEUTICS INC NEW | Healthcare | 1.9% | $18.2m | 719,836 | 27% | added |
| 13 | VTRS VIATRIS INC | Healthcare | 1.6% | $15.8m | 1,272,102 | -26% | reduced |
| 14 | UTHR UNITED THERAPEUTICS CORP DEL | Healthcare | 1.6% | $15.4m | 43,703 | -67% | reduced |
| 15 | VRDN VIRIDIAN THERAPEUTICS INC | Healthcare | 1.5% | $15.0m | 779,998 | 13% | added |
| 16 | BCRX BIOCRYST PHARMACEUTICALS INC | Healthcare | 1.5% | $14.9m | 1,980,312 | 270% | added |
| 17 | BRKR BRUKER CORP | Healthcare | 1.4% | $13.8m | 234,934 | – | new |
| 18 | EW EDWARDS LIFESCIENCES CORP | Healthcare | 1.3% | $12.6m | 170,678 | – | new |
| 19 | DXCM DEXCOM INC | Healthcare | 1.2% | $11.6m | 148,688 | – | new |
| 20 | CNC CENTENE CORP DEL | Healthcare | 1.2% | $11.4m | 188,493 | 40% | added |
| 21 | TFX TELEFLEX INCORPORATED | Healthcare | 1.1% | $11.0m | 61,736 | – | new |
| 22 | ELV ELEVANCE HEALTH INC | Healthcare | 1.1% | $10.8m | 29,178 | 50% | added |
| 23 | PCVX VAXCYTE INC | Healthcare | 1.1% | $10.4m | 127,588 | – | new |
| 24 | TVTX TRAVERE THERAPEUTICS INC | Healthcare | 0.9% | $8.5m | 490,296 | -44% | reduced |
| 25 | CYH COMMUNITY HEALTH SYS INC NEW | Healthcare | 0.9% | $8.5m | 2,827,000 | -68% | reduced |
| 26 | GH GUARDANT HEALTH INC | Healthcare | 0.9% | $8.4m | 276,036 | – | new |
| 27 | RGEN REPLIGEN CORP | Healthcare | 0.8% | $7.8m | 54,066 | -67% | reduced |
| 28 | IONS IONIS PHARMACEUTICALS INC | Healthcare | 0.8% | $7.5m | 214,952 | -54% | reduced |
| 29 | FTRE FORTREA HLDGS INC | Healthcare | 0.8% | $7.5m | 401,733 | -12% | reduced |
| 30 | NEWAMSTERDAM PHARMA COMPANY | 0.7% | $7.1m | 275,362 | -10% | reduced | |
| 31 | AZN ASTRAZENECA PLC | Healthcare | 0.7% | $6.7m | 102,661 | – | new |
| 32 | LQDA LIQUIDIA CORPORATION | Healthcare | 0.7% | $6.7m | 571,305 | 314% | added |
| 33 | MEDP MEDPACE HLDGS INC | Healthcare | 0.7% | $6.3m | 19,049 | – | new |
| 34 | XENE XENON PHARMACEUTICALS INC | Healthcare | 0.6% | $6.1m | 155,540 | – | new |
| 35 | MNKD MANNKIND CORP | Healthcare | 0.6% | $5.9m | 911,025 | -54% | reduced |
| 36 | HUM HUMANA INC | Healthcare | 0.6% | $5.8m | 22,682 | -33% | reduced |
| 37 | HSIC HENRY SCHEIN INC | Healthcare | 0.6% | $5.6m | 80,303 | – | new |
| 38 | DHR DANAHER CORPORATION | Healthcare | 0.5% | $5.1m | 22,209 | -42% | reduced |
| 39 | SNDX SYNDAX PHARMACEUTICALS INC | Healthcare | 0.5% | $4.5m | 343,400 | -92% | reduced |
| 40 | PDCOEUR PATTERSON COS INC | 0.5% | $4.5m | 146,051 | – | new | |
| 41 | GOSS GOSSAMER BIO INC | Healthcare | 0.5% | $4.5m | 4,978,458 | 0% | held |
| 42 | EOLS EVOLUS INC | Healthcare | 0.4% | $4.2m | 383,045 | -15% | reduced |
| 43 | ICLR ICON PLC | Healthcare | 0.4% | $4.0m | 19,252 | 41% | added |
| 44 | SUPN SUPERNUS PHARMACEUTICALS INC | Healthcare | 0.4% | $3.8m | 105,581 | – | new |
| 45 | AVTR AVANTOR INC | Healthcare | 0.4% | $3.5m | 168,369 | 0% | held |
| 46 | PBYI PUMA BIOTECHNOLOGY INC | Healthcare | 0.3% | $3.0m | 996,102 | -23% | reduced |
| 47 | TSVT* 2SEVENTY BIO INC | 0.3% | $3.0m | 1,003,678 | 1% | added | |
| 48 | MERUS N V | 0.3% | $2.9m | 68,258 | 0% | held | |
| 49 | MREO MEREO BIOPHARMA GROUP PLC | Healthcare | 0.3% | $2.7m | 777,890 | 0% | held |
| 50 | ZLAB ZAI LAB LTD | Healthcare | 0.3% | $2.7m | 102,930 | -24% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.